Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
International Journal of Cancer
|
March 18, 2025
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study
Mathieu Virazels, Amélie Lusque, Stéphanie Brayer, et al.
Cancer Research
|
June 4, 2009
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer
Feng Qian, Jeannine Villella, Paul K Wallace, et al.
Oncoimmunology
|
November 1, 2021
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers
Juan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, et al.
Cell Reports
|
January 4, 2019
Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells
Don-Marc Franchini, Olivia Lanvin, Marie Tosolini, et al.
The Journal of Investigative Dermatology
|
February 2, 2016
Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
Nicolas Jacquelot, María Paula Roberti, David P Enot, et al.
Frontiers in Oncology
|
December 11, 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer
Jonathan Khalifa, Noémie Thébault, Clara-Maria Scarlata, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Circulating CD14<sup>high</sup> CD16<sup>low</sup> intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
Mélissa Prat, Augustin Le Naour, Kimberley Coulson, et al.
Immunological Reviews
|
November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma
Pedro Romero, Danila Valmori, Mikael J Pittet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2007
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori, Naira E Souleimanian, Valeria Tosello, et al.
Cancer Research
|
November 8, 2013
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering
Ana I Romero, Nathalie Chaput, Vichnou Poirier-Colame, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
International Journal of Cancer
|
March 18, 2025
TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study
Mathieu Virazels, Amélie Lusque, Stéphanie Brayer, et al.
Cancer Research
|
June 4, 2009
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer
Feng Qian, Jeannine Villella, Paul K Wallace, et al.
Oncoimmunology
|
November 1, 2021
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers
Juan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, et al.
Cell Reports
|
January 4, 2019
Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells
Don-Marc Franchini, Olivia Lanvin, Marie Tosolini, et al.
The Journal of Investigative Dermatology
|
February 2, 2016
Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
Nicolas Jacquelot, María Paula Roberti, David P Enot, et al.
Frontiers in Oncology
|
December 11, 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer
Jonathan Khalifa, Noémie Thébault, Clara-Maria Scarlata, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Circulating CD14<sup>high</sup> CD16<sup>low</sup> intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
Mélissa Prat, Augustin Le Naour, Kimberley Coulson, et al.
Immunological Reviews
|
November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma
Pedro Romero, Danila Valmori, Mikael J Pittet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2007
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori, Naira E Souleimanian, Valeria Tosello, et al.
Cancer Research
|
November 8, 2013
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering
Ana I Romero, Nathalie Chaput, Vichnou Poirier-Colame, et al.
Page
of 9